Your search returned 2 results.

Results
	1.	Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. [electronic resource] by Keystone, E Burmester, G R Furie, R Loveless, J E Emery, P Kremer, J Tak, P P Broder, M S Yu, E Cravets, M Magrini, F Jost, F Producer: 20080724 In: Arthritis and rheumatism vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. [electronic resource] by Keystone, E Emery, P Peterfy, C G Tak, P P Cohen, S Genovese, M C Dougados, M Burmester, G R Greenwald, M Kvien, T K Williams, S Hagerty, D Cravets, M W Shaw, T Producer: 20090225 In: Annals of the rheumatic diseases vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search